Results 71 to 80 of about 348 (105)

Insights to Clinical Use of Serial Determination in Titers of Cyclic Citrullinated Peptide Autoantibodies

open access: yesMediators of Inflammation, 2007
Anti-cyclic citrullinated peptide (CCP) antibody is a useful marker for the diagnosis and prognosis of rheumatoid arthritis (RA). Recently, clinical significance of follow-up in anti-CCP antibody titer has been pointed out.
Toshiaki Kogure   +4 more
doaj   +1 more source

Lung Ultrasound for the Detection of Radiologic Progression of Interstitial Lung Abnormalities in Patients With Rheumatoid Arthritis

open access: yesArthritis &Rheumatology, Volume 78, Issue 11, Page 2221-2231, November 2026.
Objective Interstitial lung disease (ILD) is an important extra‐articular manifestation of rheumatoid arthritis (RA) associated with high mortality and morbidity. Lung ultrasonography (LUS) has recently emerged as a possible screening tool. We assessed the role of LUS in monitoring radiologic progression and the development of new interstitial lung ...
Marie Vermant   +15 more
wiley   +1 more source

Autoantibodies Serum Level and 10-Year Risk of Fractures Evaluated by FRAX® Tool in Rheumatoid Arthritis Patients

open access: yesOpen Access Rheumatology: Research and Reviews
Rim Sghiri,1,* Hana Ben Hassine,2,* Mariam Ghozzi,2 Nejla El Amri,3 Khadija Baccouche,3 Rihab Sarraj,3 Zahid Shakoor,1 Adel Almogren,1 Elyes Bouajina3 1Immunology Unit, Department of Pathology, College of Medicine, King Saud University, Riyadh ...
Sghiri R   +8 more
doaj  

Machine Learning to Predict Remission Between 6 and 24 Months in Rheumatoid Arthritis: Insights From JAK, an International Registry Collaboration

open access: yesArthritis &Rheumatology, Volume 78, Issue 11, Page 2232-2245, November 2026.
Objective To develop, externally validate, and simplify a machine learning model to predict remission between 6 and 24 months in patients with rheumatoid arthritis (RA) initiating tumor necrosis factor inhibitors, JAK inhibitors, interleukin‐6 inhibitors, abatacept, or rituximab using data from 11 international registries in the JAK‐pot collaboration ...
Zubeyir Salis   +22 more
wiley   +1 more source

Unexplained Optic Neuritis and New Heart Block: A Diagnostically Challenging Case of Probable Sarcoidosis

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Sarcoidosis is a systemic inflammatory disease of unknown etiology and manifests in multiple forms. It can affect several organs within the body; however, the lungs and intra‐thoracic lymph nodes are involved in the majority of cases. Diagnosis can be challenging due to the diversity of presentation and similarities to other systemic diseases.
Chetan Kamath   +4 more
wiley   +1 more source

A Case of Recurrent Gastric Cancer in Which Rheumatoid Arthritis and Sjögren's Syndrome Became Evident With Nivolumab

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT A 59‐year‐old man with recurrent gastric cancer began nivolumab as third‐line therapy and subsequently experienced joint pain and dry eyes. Symptoms worsened despite NSAIDs. He was diagnosed with rheumatoid arthritis and Sjögren's syndrome, associated with nivolumab, and was successfully treated with immunosuppressive and anti‐rheumatic ...
Haruhiko Takemoto   +7 more
wiley   +1 more source

Diagnostic Pitfall: Mixed Connective Tissue Disease‐Associated Pulmonary Hypertension Presenting With Postpartum Right‐Sided Heart Failure in a 21‐Year‐Old—Case Report

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Mixed connective tissue disease is a multisystem autoimmune condition characterized by overlapping clinical and serological features related to anti‐U1‐RNP antibodies of at least two connective tissue diseases. It may present with myocarditis, pericarditis, pulmonary arterial hypertension, and, less commonly, heart failure.
Sai Santhosha Mrudula Alla   +10 more
wiley   +1 more source

C3a‐C3aR Signaling Modulates Neutrophil Extracellular Traps Formation and Contributes to Blood–Brain Barrier Injury After Stroke

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 11, November 2026.
Following ischemic stroke, C3a‐C3aR signaling was associated with increased neutrophil extracellular traps (NETs) formation, blood–brain barrier (BBB) disruption, and neurological impairment. Pharmacological modulation of C3a‐C3aR signaling or NETs formation attenuated BBB injury and improved neurological outcomes, supporting a potential role of C3a ...
Qingtong Zhang   +7 more
wiley   +1 more source

Atherosclerosis: From Pathogenesis to Therapeutic Interventions

open access: yesMedComm, Volume 7, Issue 11, November 2026.
The diagram outlines the core mechanisms driving atherosclerosis, including endothelial dysfunction, inflammatory responses, phenotypic switching of smooth muscle cells, and the gut–vascular axis. It also presents the corresponding therapeutic approaches now under development, such as gene therapies, immunotherapies, and nanotechnology platforms ...
Enge Zhou   +9 more
wiley   +1 more source

Neutrophil Extracellular Traps: From Mechanistic Insights to Therapeutic Targeting

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Neutrophil extracellular traps act as multimodal signal processors in cancer via three mechanisms: biomechanical scaffolds activating integrin–FAK signaling and excluding immune cells; immunometabolic hubs driving glycolysis and immunosuppression; and signal‐integration platforms synergistically activating oncogenic pathways.
Hongjie Fan   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy